In the present study, we show that FGF8 is overexpressed in advanced CRC and promotes proliferation and metastasis of CRC cells by activating YAP1, suggesting FGF8 is a potential therapeutic target in CRC. This evidence concerns the gene YAP1 and colorectal carcinoma.